Global Microcrystalline Cellulose Market is valued at USD 976.4 Million in 2021 and expected to reach USD 1440.3 Million by 2028 with a CAGR of 5.71% over the forecast period. Microcrystalline Cellulose Market Global Size, Trends, Competitive, Historical & Forecast Analysis to 2022-2028, Increasing growth of pharmaceutical industry and rising consumption of processed food are some of the major factors driving the growth of the Global Microcrystalline Cellulose Market.
Scope of Global Microcrystalline Cellulose Market: Microcrystalline cellulose (MCC) is also known for refined wood pulp and it is used as a substitute for many products while producing food and also used in medicines. The common form of microcrystalline cellulose is used for vitamin supplements or tablets. It is also
used
in
plate
analysis
for
counting
viruses,
as
an
alternative
carboxymethylcellulose.
Microcrystalline Cellulose Manufacturers Microcrystalline Cellulose Market report covers prominent players like: • • • • • • • • • • • • •
DowDuPont Asahi Kasei Chemicals Corporation Avantor Performance Materials Inc. Accent Microcell Pvt. Ltd. Anhui Sunhere Pharmaceutical Excipients Co., Ltd. DFE Pharma GmbH & Co.Kg The Dow Chemical Company Foodchem International Corporation Gujarat Microwax Limited Fibenol Huzhou City Linghu Xinwang Chemical Co., Ltd. JRS Pharma GmbH & Co. Kg. Others
Global Microcrystalline Cellulose Market Segmentation:
to
The Global Microcrystalline Cellulose market is segmented on the basis of source type, application and region & country level. On the basis of type, the global microcrystalline cellulose market is classified as wood-based and non-wood-based. Based on application, the global microcrystalline cellulose market is segmented as food & beverage, pharmaceutical, cosmetics & personal care, and others. By Source Types: • •
Wood-Based Non-Wood Based
By Applications: • • • •
Food & Beverage Pharmaceutical Cosmetics & Personal Care Others
News: DFE Pharma Launched Pharmacel sMCC 90 On July 7th, 2021; DFE Pharma, a provider of pharmaceutical excipient solutions, launched Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). Pharmacel sMCC 90 has been developed as the synergistic solution for challenging oral solid dosage formulations. Among several advancements in formulation science, co-processed excipients are gaining popularity as they offer effective means to rapidly develop products for early human trials, while minimizing the risk to product quality.
Asahi Kasei Built a Second Plant for Ceolus Microcrystalline Cellulose On January 13th, 2021; Asahi Kasei's Specialty Solutions SBU built a second plant for microcrystalline cellulose at its Mizushima Works in Kurashiki, Okayama, Japan. Asahi Kasei currently manufacturing Ceolus, microcrystalline cellulose used primarily in pharmaceuticals as tablet binder, in Nobeoka, Miyazaki, Japan. Besides the standard-type product PH series, Ceolus has a lineup of KG series that greatly enhances the compatibility of tablets and the UF series that combines compatibility and flowability. These products
provide solutions to a wide range of issues in the production of tablets for pharmaceuticals and supplements.
Key Benefits of Global Microcrystalline Cellulose Market Report: • •
• •
Global Microcrystalline Cellulose market report covers in-depth historical and forecast analysis. Global Microcrystalline Cellulose market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. Global Microcrystalline Cellulose market report helps to identify opportunities in the marketplace. Global Microcrystalline Cellulose market report covers extensive analysis of emerging trends and competitive landscape.